Javier de Castro - JoVE Visualize

Showing results (131-140 of 180) with videos related to

Pageof 18

Sort By:

Theranostics|November 22, 2017

DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer CellsOlga Vera, Julia Jimenez, Olga Pernia, et al.

International Journal of Molecular Sciences|June 28, 2023

Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based ChemotherapyJavier Guijarro-Eguinoa, Sara Arjona-Hernandez, Stefan Stewart, et al.

Life (Basel, Switzerland)|July 28, 2026

Real-World Insights into Stage I-III Non-Small Cell Lung Cancer in Spain in the Pre-Immunotherapy Era Using AI Techniques: The IntellyLUNG StudyJesús Corral Jaime, Javier de Castro, Aitor Azkarate, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.

The Lancet. Oncology|September 4, 2025

Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trialJordi Remon, Paolo Bironzo, Nicolas Girard, et al.

Biomarker Research|October 20, 2023

MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancerMiranda Burdiel, Julia Jiménez, Carlos Rodríguez-Antolín, et al.

Frontiers in Medicine|August 28, 2025

Monoclonal antibodies in severe asthma: outcomes from real-world dataSilvia Del-Barrio-Buesa, Álvaro Narrillos-Moraza, Julia García-de-Pedro, et al.

Translational Research : the Journal of Laboratory and Clinical Medicine|July 28, 2018

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen speciesOlga Vera-Puente, Carlos Rodriguez-Antolin, Ana Salgado-Figueroa, et al.

Cancer Biology & Therapy|October 17, 2007

Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cellsCristóbal Belda-Iniesta, Rosario Perona, Javier de Castro Carpeño, et al.

ESMO Open|December 7, 2017

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancerFiona Blackhall, D Ross Camidge, Alice T Shaw, et al.

Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:

Pageof 18

Theranostics|November 22, 2017

DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer CellsOlga Vera, Julia Jimenez, Olga Pernia, et al.

International Journal of Molecular Sciences|June 28, 2023

Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based ChemotherapyJavier Guijarro-Eguinoa, Sara Arjona-Hernandez, Stefan Stewart, et al.

Life (Basel, Switzerland)|July 28, 2026

Real-World Insights into Stage I-III Non-Small Cell Lung Cancer in Spain in the Pre-Immunotherapy Era Using AI Techniques: The IntellyLUNG StudyJesús Corral Jaime, Javier de Castro, Aitor Azkarate, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.

The Lancet. Oncology|September 4, 2025

Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trialJordi Remon, Paolo Bironzo, Nicolas Girard, et al.

Biomarker Research|October 20, 2023

MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancerMiranda Burdiel, Julia Jiménez, Carlos Rodríguez-Antolín, et al.

Frontiers in Medicine|August 28, 2025

Monoclonal antibodies in severe asthma: outcomes from real-world dataSilvia Del-Barrio-Buesa, Álvaro Narrillos-Moraza, Julia García-de-Pedro, et al.

Translational Research : the Journal of Laboratory and Clinical Medicine|July 28, 2018

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen speciesOlga Vera-Puente, Carlos Rodriguez-Antolin, Ana Salgado-Figueroa, et al.

Cancer Biology & Therapy|October 17, 2007

Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cellsCristóbal Belda-Iniesta, Rosario Perona, Javier de Castro Carpeño, et al.

ESMO Open|December 7, 2017

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancerFiona Blackhall, D Ross Camidge, Alice T Shaw, et al.

Pageof 18